120 related articles for article (PubMed ID: 11274656)
1. Chronic myo-inositol increases rat brain phosphatidylethanolamine plasmalogen.
Pettegrew JW; Panchalingam K; Levine J; McClure RJ; Gershon S; Yao JK
Biol Psychiatry; 2001 Mar; 49(5):444-53. PubMed ID: 11274656
[TBL] [Abstract][Full Text] [Related]
2. Studies of myo-inositol and plasmalogen metabolism in rat brain.
Hoffman-Kuczynski B; Reo NV
Neurochem Res; 2004 Apr; 29(4):843-55. PubMed ID: 15098950
[TBL] [Abstract][Full Text] [Related]
3. Administration of myo-inositol plus ethanolamine elevates phosphatidylethanolamine plasmalogen in the rat cerebellum.
Hoffman-Kuczynski B; Reo NV
Neurochem Res; 2005 Jan; 30(1):47-60. PubMed ID: 15756932
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic lithium administration on rat brain phosphatidylinositol cycle constituents, membrane phospholipids and amino acids.
Pettegrew JW; Panchalingam K; McClure RJ; Gershon S; Muenz LR; Levine J
Bipolar Disord; 2001 Aug; 3(4):189-201. PubMed ID: 11552958
[TBL] [Abstract][Full Text] [Related]
5. Oral bioavailability of the ether lipid plasmalogen precursor, PPI-1011, in the rabbit: a new therapeutic strategy for Alzheimer's disease.
Wood PL; Smith T; Lane N; Khan MA; Ehrmantraut G; Goodenowe DB
Lipids Health Dis; 2011 Dec; 10():227. PubMed ID: 22142382
[TBL] [Abstract][Full Text] [Related]
6. Lithium alters regional rat brain myo-inositol at 2 and 4 weeks: an ex-vivo magnetic resonance spectroscopy study at 18.8 T.
McGrath BM; Greenshaw AJ; McKay R; Slupsky CM; Silverstone PH
Neuroreport; 2006 Aug; 17(12):1323-6. PubMed ID: 16951578
[TBL] [Abstract][Full Text] [Related]
7. Influence of Myo-inositol Plus Ethanolamine on Plasmalogens and Cell Viability during Oxidative Stress.
Sibomana I; Grobe N; DelRaso NJ; Reo NV
Chem Res Toxicol; 2019 Feb; 32(2):265-284. PubMed ID: 30604967
[TBL] [Abstract][Full Text] [Related]
8. Acute dextro-amphetamine administration does not alter brain myo-inositol levels in humans and animals: MRS investigations at 3 and 18.8 T.
McGrath BM; McKay R; Dave S; Seres P; Weljie AM; Slupsky CM; Hanstock CC; Greenshaw AJ; Silverstone PH
Neurosci Res; 2008 Aug; 61(4):351-9. PubMed ID: 18508145
[TBL] [Abstract][Full Text] [Related]
9. Rat brain monoamines after acute and chronic myo-inositol treatment.
Einat H; Belmaker RH; Kopilov M; Klein E; Gazawi H; Ben-Shachar D
Eur Neuropsychopharmacol; 1999 Dec; 10(1):27-30. PubMed ID: 10647093
[TBL] [Abstract][Full Text] [Related]
10. Epi-inositol and inositol depletion: two new treatment approaches in affective disorder.
Bersudsky Y; Einat H; Stahl Z; Belmaker RH
Curr Psychiatry Rep; 1999 Dec; 1(2):141-7. PubMed ID: 11122916
[TBL] [Abstract][Full Text] [Related]
11. Evidence that plasmalogen is protective against oxidative stress in the rat brain.
Kuczynski B; Reo NV
Neurochem Res; 2006 May; 31(5):639-56. PubMed ID: 16770735
[TBL] [Abstract][Full Text] [Related]
12. Effects of myo-inositol ingestion on human brain myo-inositol levels: a proton magnetic resonance spectroscopic imaging study.
Moore CM; Breeze JL; Kukes TJ; Rose SL; Dager SR; Cohen BM; Renshaw PF
Biol Psychiatry; 1999 May; 45(9):1197-202. PubMed ID: 10331112
[TBL] [Abstract][Full Text] [Related]
13. Chronic lithium and sodium valproate both decrease the concentration of myo-inositol and increase the concentration of inositol monophosphates in rat brain.
O'Donnell T; Rotzinger S; Nakashima TT; Hanstock CC; Ulrich M; Silverstone PH
Brain Res; 2000 Oct; 880(1-2):84-91. PubMed ID: 11032992
[TBL] [Abstract][Full Text] [Related]
14. Effects of acetyl-L-carnitine and myo-inositol on high-energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P-NMR-spectroscopy study.
Levine J; Panchalingam K; McClure RJ; Gershon S; Pettegrew JW
Neurochem Res; 2003 May; 28(5):687-90. PubMed ID: 12716017
[TBL] [Abstract][Full Text] [Related]
15. Temporal dissociation between lithium-induced changes in frontal lobe myo-inositol and clinical response in manic-depressive illness.
Moore GJ; Bebchuk JM; Parrish JK; Faulk MW; Arfken CL; Strahl-Bevacqua J; Manji HK
Am J Psychiatry; 1999 Dec; 156(12):1902-8. PubMed ID: 10588403
[TBL] [Abstract][Full Text] [Related]
16. Effects of systemically administered lithium on phosphoinositide metabolism in rat brain, kidney, and testis.
Sherman WR; Munsell LY; Gish BG; Honchar MP
J Neurochem; 1985 Mar; 44(3):798-807. PubMed ID: 2983019
[TBL] [Abstract][Full Text] [Related]
17. Serum Ethanolamine Plasmalogen and Urine Myo-Inositol as Cognitive Decline Markers.
Maeba R; Araki A; Fujiwara Y
Adv Clin Chem; 2018; 87():69-111. PubMed ID: 30342713
[TBL] [Abstract][Full Text] [Related]
18. Myo-inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome.
Maeba R; Hara H; Ishikawa H; Hayashi S; Yoshimura N; Kusano J; Takeoka Y; Yasuda D; Okazaki T; Kinoshita M; Teramoto T
J Nutr Sci Vitaminol (Tokyo); 2008 Jun; 54(3):196-202. PubMed ID: 18635905
[TBL] [Abstract][Full Text] [Related]
19. Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.
Forester BP; Finn CT; Berlow YA; Wardrop M; Renshaw PF; Moore CM
Bipolar Disord; 2008 Sep; 10(6):691-700. PubMed ID: 18837863
[TBL] [Abstract][Full Text] [Related]
20. Alcohol acutely depresses myo-inositol 1-phosphate levels in the male rat cerebral cortex.
Allison JH; Cicero TJ
J Pharmacol Exp Ther; 1980 Apr; 213(1):24-7. PubMed ID: 7359367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
